Inventor · disambiguated record
Jun Li
Also filed as: LI JUN · LI JUN M
22 granted patents·24 pending applications·207 citations·filing 1997–2024
94Inventor score
Files withGENENTECH INC17TYK MEDICINES INC9TYK MEDICINES ZHENGZHOU INC3ARRAY BIOPHARMA INC2UNIV OREGON STATE2
Top patents by PatentIndex Score
46 records- 0197US9980947B2Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted May 29, 2018·17 cites·87 claims
- 0295US11027027B2Pyridazinoindole compounds and methods for PET imagingUNIV VANDERBILT·Filed 2016·Granted Jun 8, 2021·31 cites·7 claims
- 0395US8952169B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Feb 10, 2015·25 cites·43 claims
- 0495US8003651B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2007·Granted Aug 23, 2011·35 cites·76 claims
- 0592US10966963B2Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2018·Granted Apr 6, 2021·10 cites·32 claims
- 0692US9694002B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Jul 4, 2017·11 cites·10 claims
- 0792US9546164B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2015·Granted Jan 17, 2017·13 cites·38 claims
- 0888US8846681B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Sep 30, 2014·11 cites·91 claims
- 0986US2025114338A1TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOFGENENTECH INC·Filed 2024·Application pending·0 cites
- 1083US10654867B2Heteroaryl estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2019·Granted May 19, 2020·1 cites·5 claims
- 1175US8293736B2Purine compounds selective for PI3K P110 delta, and methods of useLI JUN·Filed 2011·Granted Oct 23, 2012·3 cites·15 claims
- 1274US5767134AProdrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMPVION PHARMACEUTICALS INC·Filed 1997·Granted Jun 16, 1998·37 cites·21 claims
- 1372US12233052B2Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2021·Granted Feb 25, 2025·0 cites·32 claims
- 1471US2025051179A1Compounds having a thortveitite-related structure and methods for making and usingUNIV OREGON STATE·Filed 2024·Application pending·0 cites
- 1569US2021093618A1Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 1667US2020108054A1Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 1765US5869676AProcess for the synthesis of ribonucleotide reductase inhibitors 3-AP and 3-AMPVION PHARMACEUTICALS INC·Filed 1997·Granted Feb 9, 1999·13 cites·12 claims
- 1858US2014349996A1Pyrimidyl cyclopentanes as akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Application pending·0 cites
- 1956US2018002344A1Heteroaryl estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 2056US2017002017A1N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Application pending·0 cites
- 2155US9758385B2Compounds comprising a hibonite structure and a method for their useUNIV OREGON STATE·Filed 2016·Granted Sep 12, 2017·0 cites·25 claims
- 2255US2025129086A1Compound for degrading egfr protein and use thereofTYK MEDICINES INC·Filed 2022·Application pending·0 cites
- 2352US2019152970A1TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOFGENENTECH INC·Filed 2019·Application pending·0 cites
- 2450US2025154105A1Polycyclic compound and use thereofTYK MEDICINES INC·Filed 2022·Application pending·0 cites
- 2549US12435089B23-oxadiazolyl substituted pyrazolo[1,5,a]pyrimidines for ROS1, NTRK, and ALK mediated diseasesTYK MEDICINES INC·Filed 2021·Granted Oct 7, 2025·0 cites·11 claims
- 2649US2024190887A1Compound used as shp2 inhibitor and use thereofTYK MEDICINES INC·Filed 2022·Application pending·0 cites
- 2749US2024025908A1Compound used as kinase inhibitor and use thereofTYK MEDICINES INC·Filed 2021·Application pending·0 cites
- 2848US2017362228A1TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOFGENENTECH INC·Filed 2017·Application pending·0 cites
- 2946US2024287065A1Compound as cdk kinase inhibitor and use thereofTYK MEDICINES ZHENGZHOU INC·Filed 2022·Application pending·0 cites
- 3045US2015031571A1Chemiluminescent nanoparticles and uses thereofUNIV KANSAS·Filed 2013·Application pending·0 cites
- 3144US7749994B2Pentacyclic kinase inhibitorsGENENTECH INC·Filed 2006·Granted Jul 6, 2010·0 cites·17 claims
- 3244US2023095530A1Compound used as ret kinase inhibitor and application thereofTYK MEDICINES INC·Filed 2020·Application pending·0 cites
- 3344US2023089014A1Compound used as kinase inhibitor and use thereofTYK MEDICINES ZHENGZHOU INC·Filed 2021·Application pending·0 cites
- 3443US12509441B2Compounds used as kinase inhibitors and application thereofTYK MEDICINES ZHENGZHOU INC·Filed 2021·Granted Dec 30, 2025·0 cites·2 claims
- 3542US2023026840A1Compound used as egfr kinase inhibitor and use thereofTYK MEDICINES INC·Filed 2020·Application pending·0 cites
- 3641US2022233513A1Compound used as ret kinase inhibitor and application thereofTYK MEDICINES INC·Filed 2020·Application pending·0 cites
- 3740US10179767B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Jan 15, 2019·0 cites·6 claims
- 3840US9365672B2Polylactic acid block copolymers and preparation methods thereofZHOU JIAN·Filed 2011·Granted Jun 14, 2016·0 cites·20 claims
- 3938US2023295130A1Compound useful as cdk7 kinase inhibitor and use thereofTYK MEDICINES INC·Filed 2021·Application pending·0 cites
- 4037US2016175284A1Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Application pending·0 cites
- 4135US2010256421A1Propanal Production MethodsLAUGHLIN IND CO LTD O·Filed 2010·Application pending·0 cites
- 4233US8110703B2Retinoid derivative and pharmaceutical composition and use thereofCHEN FEIHU·Filed 2009·Granted Feb 7, 2012·0 cites·8 claims
- 4332US10883085B2PRRSV SX-105 strain and use thereofINST ANIMAL SCIENCE & VETERINARY MEDICINE SHANDONG AAS·Filed 2015·Granted Jan 5, 2021·0 cites·5 claims
- 4432US2016352251A1Active Neutral-Point-Clamped (ANPC) Converters and Operating Methods ThereofABB TECHNOLOGY AG·Filed 2015·Application pending·0 cites
- 4531US2018353592A1Combined application of Haemophilus parasuis LC strain and Haemophilus parasuis LZ-20100109 stainINST OF ANIMAL SCIENECE AND VETERINARY MEDICINE SHANDONG ACADEMY OF AGRICULTARAL SCIENCES·Filed 2015·Application pending·0 cites
- 4624US8986683B2Combined use of ribonuclease and artemisininWANG QINGCHENG·Filed 2012·Granted Mar 24, 2015·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Jun Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →